© 2019 by Georgia Bio. Proudly created with Wix.com

#GaBioSummit

TRACK D - Medical Device & Digital Health:

Cybersecurity: The Complexities Facing Your Life Science Business

Cybersecurity continues to be a high-profile topic across many verticals but is especially so for the life science industry, and for very good reason. Cyberthreats and the solutions used to fight them are evolving at an extraordinary rate. While you think you may not fit the default risk/attack profile, you possess priceless information and resources valuable to hackers.

 

Join in on this panel discussion as we dive into the ever-evolving world of cyber threats. We’ll focus on the evolving cybersecurity landscape, the importance and benefits cybersecurity systems, and the data breach legal requirements within the Life Science and Biotech ecosystem.

Christopher Messer
Chief Technology Officer, Coretelligent
Moderator

Chris is a transformational and strategic IT leader who establishes and leads Coretelligent’s technical vision and technological development. He partners with the executive management team to grow the company through the use of technological resources.

With a passion for problem-solving, Chris advises organizations of all sizes on their technology strategies and helps develop custom IT roadmaps for private, public and hybrid cloud deployments. He oversees the technical teams responsible for key Coretelligent platforms, as well as project engineering and the Principal Solutions Architecture team, liaising with top clientele.

With more than 15 years’ experience in technology administration, design and implementation, Chris joined Coretelligent in 2007 as a field engineer supporting clientele within the financial services space. He advanced to his current role in parallel with the company’s accelerated growth, testimony to his significant technical contributions and leadership.

Outside the office, Chris enjoys mountain biking and hiking in his native state of New Hampshire. His passion for technology extends to his home lab, where he is constantly building and testing new technologies and hardware.  He also enjoys traveling with his wife and stepdaughters, exploring the mountains and seacoast regions of New England.

Marta New, PhD, MBA
Investor

Most recently, Marta was the co-founding Partner at Agent Capital, LLC, a life sciences-focused venture capital firm based in Cambridge, MA, investing in oncology, immunology and rare disease therapeutics companies. Marta started her investment career at Baxter Ventures, the corporate venture capital arm of Baxter Healthcare in Chicago, IL, transitioning from the Global Renal Marketing franchise, where she was the commercial lead for multiple new medical device products for the Chinese and European markets. She joined Baxter from Northwestern University’s Innovation and New Ventures Office where she was responsible for licensing negotiations, commercial assessment of patents, and industry alliance management. Marta received her PhD from the University of Illinois at Chicago in microbiology and immunology and completed her post-doctoral training at Northwestern University. She also received an MBA from Northwestern University Kellogg School of Management in Chicago, IL.

Peter Ritter
Manager - Global MSSP, BlackBerry Cylance

Peter Ritter is the Manager of Global MSSP for Cylance with more than 20 years’ experience providing information security solutions to enterprises. Over the past 10 years, Peter has worked in collaboration with global enterprise security organizations to identify key technologies and operational improvements to address their security needs and compliance requirements. He has led organizations into strategic partnerships with innovative technology companies to mitigate risk to their security posture. Peter’s specialty most recently is focused on the sales operational aspects of the BlackBerry Cylance MSSP and working directly with our Partners to leverage Cylance within their practices. 

Rajeev Sukumaran
Executive Director, IT Legal & Compliance,
Boehringer Ingelheim

Rajeev Sukumaran is IT Executive Director at Boehringer Ingelheim, with responsibility for teams supporting global functions of Learning, Legal and Compliance as well as US Oracle ERP. As a Senior IT Executive, he has driven organizational transformation through “Business Value Focus” effectively aligning technology strategies with business needs. He has held multiple global and local management positions in pharmaceutical and IT service provider industries, building and structuring organizations and IT services that drive revenue and optimize cost control. His prior achievements include transforming large IT organization into a global unit, blending strategies such as in-sourcing, out-sourcing, consolidating application portfolio management, etc. He has run hosting operations in support of multi-million dollar product marketing projects, implementing global Service Portfolio in 30+ countries and building/running validated computer system environments. He has also worked with the management team of an Ashoka Fellow founded Social Entrepreneur organization in India, to scale up their healthcare delivery programs in rural India. He is a member of Rutgers Leading Disruptive Innovation Advisory Board. He possesses a Computer Engineering degree from WIT, India and an MBA in Finance and IT from Stern School of Business, NYU.

Michael Vanderhoff
Enterprise Account Executive, Mimecast

Michael Vanderhoff is the Enterprise Account Executive for Mimecast with over fifteen years’ experience in IT security, messaging and telephony.  In his current role, Michael is responsible for driving Sales with a focus on growing Mimecast’s Enterprise client base in the Southeast. Michael has a proven track record of success in the Security space providing Cyber Resiliency in the Cloud. Michael is a graduate of Western Carolina University and holds a Bachelors Degree in Business Administration with a focus in Marketing.  In his free time, Michael enjoys spending time with his family, is an avid fly fisherman and loves everything outdoors.